nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—Prostatic disorder—Octreotide—thymus cancer	0.029	0.0313	CcSEcCtD
Gliclazide—Pancreatitis acute—Octreotide—thymus cancer	0.0267	0.0288	CcSEcCtD
Gliclazide—Haemorrhoids—Octreotide—thymus cancer	0.0209	0.0226	CcSEcCtD
Gliclazide—Hypothyroidism—Octreotide—thymus cancer	0.0192	0.0207	CcSEcCtD
Gliclazide—Nail disorder—Octreotide—thymus cancer	0.019	0.0205	CcSEcCtD
Gliclazide—Menstrual disorder—Octreotide—thymus cancer	0.0181	0.0195	CcSEcCtD
Gliclazide—Neuralgia—Octreotide—thymus cancer	0.0177	0.0191	CcSEcCtD
Gliclazide—Cholestasis—Octreotide—thymus cancer	0.0162	0.0175	CcSEcCtD
Gliclazide—Otitis media—Octreotide—thymus cancer	0.0158	0.0171	CcSEcCtD
Gliclazide—Nephrolithiasis—Octreotide—thymus cancer	0.0153	0.0165	CcSEcCtD
Gliclazide—Numbness—Octreotide—thymus cancer	0.0149	0.016	CcSEcCtD
Gliclazide—Neoplasm malignant—Octreotide—thymus cancer	0.0144	0.0156	CcSEcCtD
Gliclazide—Sensory loss—Octreotide—thymus cancer	0.0142	0.0154	CcSEcCtD
Gliclazide—Jaundice cholestatic—Octreotide—thymus cancer	0.014	0.0151	CcSEcCtD
Gliclazide—Viral infection—Octreotide—thymus cancer	0.0136	0.0147	CcSEcCtD
Gliclazide—Arthropathy—Octreotide—thymus cancer	0.0135	0.0146	CcSEcCtD
Gliclazide—Hearing impaired—Octreotide—thymus cancer	0.0129	0.014	CcSEcCtD
Gliclazide—Vaginal inflammation—Octreotide—thymus cancer	0.0123	0.0133	CcSEcCtD
Gliclazide—Cystitis noninfective—Octreotide—thymus cancer	0.012	0.013	CcSEcCtD
Gliclazide—Cystitis—Octreotide—thymus cancer	0.0119	0.0128	CcSEcCtD
Gliclazide—Vaginal infection—Octreotide—thymus cancer	0.0116	0.0126	CcSEcCtD
Gliclazide—Neuropathy—Octreotide—thymus cancer	0.0116	0.0125	CcSEcCtD
Gliclazide—Bladder pain—Octreotide—thymus cancer	0.0111	0.012	CcSEcCtD
Gliclazide—Urine output increased—Octreotide—thymus cancer	0.0111	0.012	CcSEcCtD
Gliclazide—Sleep disorder—Octreotide—thymus cancer	0.0103	0.0112	CcSEcCtD
Gliclazide—Thrombophlebitis—Octreotide—thymus cancer	0.0103	0.0112	CcSEcCtD
Gliclazide—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.0103	0.0111	CcSEcCtD
Gliclazide—Polyuria—Octreotide—thymus cancer	0.0102	0.011	CcSEcCtD
Gliclazide—Gastroenteritis—Octreotide—thymus cancer	0.0101	0.0109	CcSEcCtD
Gliclazide—Deafness—Octreotide—thymus cancer	0.01	0.0108	CcSEcCtD
Gliclazide—Injury—Octreotide—thymus cancer	0.00973	0.0105	CcSEcCtD
Gliclazide—Visual disturbance—Octreotide—thymus cancer	0.00944	0.0102	CcSEcCtD
Gliclazide—Arthritis—Octreotide—thymus cancer	0.0092	0.00993	CcSEcCtD
Gliclazide—Hypoglycaemia—Octreotide—thymus cancer	0.00916	0.00989	CcSEcCtD
Gliclazide—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00894	0.00965	CcSEcCtD
Gliclazide—Osteoarthritis—Octreotide—thymus cancer	0.00894	0.00965	CcSEcCtD
Gliclazide—Pain in extremity—Octreotide—thymus cancer	0.00894	0.00965	CcSEcCtD
Gliclazide—Dry skin—Octreotide—thymus cancer	0.0082	0.00885	CcSEcCtD
Gliclazide—Gastritis—Octreotide—thymus cancer	0.00791	0.00854	CcSEcCtD
Gliclazide—Abdominal distension—Octreotide—thymus cancer	0.00778	0.0084	CcSEcCtD
Gliclazide—Asthma—Octreotide—thymus cancer	0.00773	0.00834	CcSEcCtD
Gliclazide—VEGFA—cardiac atrium—thymus cancer	0.00748	0.101	CbGeAlD
Gliclazide—Bronchitis—Octreotide—thymus cancer	0.00743	0.00802	CcSEcCtD
Gliclazide—Abdominal discomfort—Octreotide—thymus cancer	0.00741	0.008	CcSEcCtD
Gliclazide—VEGFA—pituitary gland—thymus cancer	0.00731	0.099	CbGeAlD
Gliclazide—Upper respiratory tract infection—Octreotide—thymus cancer	0.00718	0.00776	CcSEcCtD
Gliclazide—KCNJ11—hematopoietic system—thymus cancer	0.00705	0.0955	CbGeAlD
Gliclazide—Weight increased—Octreotide—thymus cancer	0.00703	0.00759	CcSEcCtD
Gliclazide—Hyperglycaemia—Octreotide—thymus cancer	0.00697	0.00753	CcSEcCtD
Gliclazide—Pneumonia—Octreotide—thymus cancer	0.00693	0.00748	CcSEcCtD
Gliclazide—Drowsiness—Octreotide—thymus cancer	0.00689	0.00744	CcSEcCtD
Gliclazide—Depression—Octreotide—thymus cancer	0.00687	0.00742	CcSEcCtD
Gliclazide—Neuropathy peripheral—Octreotide—thymus cancer	0.00675	0.00729	CcSEcCtD
Gliclazide—Jaundice—Octreotide—thymus cancer	0.00672	0.00725	CcSEcCtD
Gliclazide—Conjunctivitis—Octreotide—thymus cancer	0.0067	0.00723	CcSEcCtD
Gliclazide—Urinary tract infection—Octreotide—thymus cancer	0.0067	0.00723	CcSEcCtD
Gliclazide—Hepatobiliary disease—Octreotide—thymus cancer	0.00652	0.00704	CcSEcCtD
Gliclazide—Epistaxis—Octreotide—thymus cancer	0.0065	0.00702	CcSEcCtD
Gliclazide—Sinusitis—Octreotide—thymus cancer	0.00646	0.00698	CcSEcCtD
Gliclazide—VEGFA—bone marrow—thymus cancer	0.00632	0.0856	CbGeAlD
Gliclazide—VEGFA—thyroid gland—thymus cancer	0.0063	0.0853	CbGeAlD
Gliclazide—Bradycardia—Octreotide—thymus cancer	0.0063	0.0068	CcSEcCtD
Gliclazide—Rhinitis—Octreotide—thymus cancer	0.0062	0.0067	CcSEcCtD
Gliclazide—Hepatitis—Octreotide—thymus cancer	0.00619	0.00668	CcSEcCtD
Gliclazide—Hypoaesthesia—Octreotide—thymus cancer	0.00615	0.00665	CcSEcCtD
Gliclazide—Pharyngitis—Octreotide—thymus cancer	0.00614	0.00663	CcSEcCtD
Gliclazide—Oedema peripheral—Octreotide—thymus cancer	0.00609	0.00658	CcSEcCtD
Gliclazide—Visual impairment—Octreotide—thymus cancer	0.00596	0.00644	CcSEcCtD
Gliclazide—Tinnitus—Octreotide—thymus cancer	0.00577	0.00623	CcSEcCtD
Gliclazide—Flushing—Octreotide—thymus cancer	0.00574	0.0062	CcSEcCtD
Gliclazide—VEGFA—lung—thymus cancer	0.00572	0.0775	CbGeAlD
Gliclazide—Arrhythmia—Octreotide—thymus cancer	0.00553	0.00597	CcSEcCtD
Gliclazide—Mental disorder—Octreotide—thymus cancer	0.00542	0.00585	CcSEcCtD
Gliclazide—Malnutrition—Octreotide—thymus cancer	0.00538	0.00581	CcSEcCtD
Gliclazide—Erythema—Octreotide—thymus cancer	0.00538	0.00581	CcSEcCtD
Gliclazide—Flatulence—Octreotide—thymus cancer	0.00531	0.00573	CcSEcCtD
Gliclazide—Tension—Octreotide—thymus cancer	0.00528	0.00571	CcSEcCtD
Gliclazide—Nervousness—Octreotide—thymus cancer	0.00523	0.00565	CcSEcCtD
Gliclazide—Back pain—Octreotide—thymus cancer	0.00521	0.00562	CcSEcCtD
Gliclazide—Tremor—Octreotide—thymus cancer	0.00505	0.00545	CcSEcCtD
Gliclazide—Ill-defined disorder—Octreotide—thymus cancer	0.005	0.00539	CcSEcCtD
Gliclazide—Anaemia—Octreotide—thymus cancer	0.00498	0.00537	CcSEcCtD
Gliclazide—KCNJ11—lymphoid tissue—thymus cancer	0.00496	0.0672	CbGeAlD
Gliclazide—Agitation—Octreotide—thymus cancer	0.00495	0.00534	CcSEcCtD
Gliclazide—Malaise—Octreotide—thymus cancer	0.00486	0.00524	CcSEcCtD
Gliclazide—ABCC8—pituitary gland—thymus cancer	0.00482	0.0652	CbGeAlD
Gliclazide—Palpitations—Octreotide—thymus cancer	0.00476	0.00514	CcSEcCtD
Gliclazide—Loss of consciousness—Octreotide—thymus cancer	0.00473	0.00511	CcSEcCtD
Gliclazide—Cough—Octreotide—thymus cancer	0.0047	0.00507	CcSEcCtD
Gliclazide—Convulsion—Octreotide—thymus cancer	0.00467	0.00504	CcSEcCtD
Gliclazide—Hypertension—Octreotide—thymus cancer	0.00465	0.00502	CcSEcCtD
Gliclazide—Arthralgia—Octreotide—thymus cancer	0.00458	0.00495	CcSEcCtD
Gliclazide—Chest pain—Octreotide—thymus cancer	0.00458	0.00495	CcSEcCtD
Gliclazide—Myalgia—Octreotide—thymus cancer	0.00458	0.00495	CcSEcCtD
Gliclazide—Anxiety—Octreotide—thymus cancer	0.00457	0.00493	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00455	0.00492	CcSEcCtD
Gliclazide—Discomfort—Octreotide—thymus cancer	0.00453	0.00489	CcSEcCtD
Gliclazide—KCNJ11—thyroid gland—thymus cancer	0.00451	0.061	CbGeAlD
Gliclazide—Dry mouth—Octreotide—thymus cancer	0.00448	0.00484	CcSEcCtD
Gliclazide—Infection—Octreotide—thymus cancer	0.00437	0.00471	CcSEcCtD
Gliclazide—Nervous system disorder—Octreotide—thymus cancer	0.00431	0.00465	CcSEcCtD
Gliclazide—Thrombocytopenia—Octreotide—thymus cancer	0.0043	0.00465	CcSEcCtD
Gliclazide—Tachycardia—Octreotide—thymus cancer	0.00429	0.00463	CcSEcCtD
Gliclazide—Skin disorder—Octreotide—thymus cancer	0.00427	0.00461	CcSEcCtD
Gliclazide—Hyperhidrosis—Octreotide—thymus cancer	0.00425	0.00459	CcSEcCtD
Gliclazide—ABCC8—thyroid gland—thymus cancer	0.00415	0.0562	CbGeAlD
Gliclazide—Musculoskeletal discomfort—Octreotide—thymus cancer	0.004	0.00432	CcSEcCtD
Gliclazide—Insomnia—Octreotide—thymus cancer	0.00397	0.00429	CcSEcCtD
Gliclazide—Paraesthesia—Octreotide—thymus cancer	0.00395	0.00426	CcSEcCtD
Gliclazide—Dyspnoea—Octreotide—thymus cancer	0.00392	0.00423	CcSEcCtD
Gliclazide—VEGFA—lymph node—thymus cancer	0.00391	0.053	CbGeAlD
Gliclazide—Somnolence—Octreotide—thymus cancer	0.00391	0.00422	CcSEcCtD
Gliclazide—Dyspepsia—Octreotide—thymus cancer	0.00387	0.00418	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Octreotide—thymus cancer	0.00379	0.0041	CcSEcCtD
Gliclazide—Fatigue—Octreotide—thymus cancer	0.00379	0.00409	CcSEcCtD
Gliclazide—Pain—Octreotide—thymus cancer	0.00376	0.00406	CcSEcCtD
Gliclazide—Constipation—Octreotide—thymus cancer	0.00376	0.00406	CcSEcCtD
Gliclazide—CYP2C19—hematopoietic system—thymus cancer	0.00374	0.0507	CbGeAlD
Gliclazide—Feeling abnormal—Octreotide—thymus cancer	0.00362	0.00391	CcSEcCtD
Gliclazide—Gastrointestinal pain—Octreotide—thymus cancer	0.00359	0.00388	CcSEcCtD
Gliclazide—Urticaria—Octreotide—thymus cancer	0.00349	0.00377	CcSEcCtD
Gliclazide—Body temperature increased—Octreotide—thymus cancer	0.00347	0.00375	CcSEcCtD
Gliclazide—Abdominal pain—Octreotide—thymus cancer	0.00347	0.00375	CcSEcCtD
Gliclazide—Hypersensitivity—Octreotide—thymus cancer	0.00324	0.0035	CcSEcCtD
Gliclazide—Asthenia—Octreotide—thymus cancer	0.00315	0.0034	CcSEcCtD
Gliclazide—Pruritus—Octreotide—thymus cancer	0.00311	0.00336	CcSEcCtD
Gliclazide—Diarrhoea—Octreotide—thymus cancer	0.00301	0.00325	CcSEcCtD
Gliclazide—Dizziness—Octreotide—thymus cancer	0.00291	0.00314	CcSEcCtD
Gliclazide—CYP2C9—hematopoietic system—thymus cancer	0.0029	0.0393	CbGeAlD
Gliclazide—KCNJ11—lymph node—thymus cancer	0.0028	0.0379	CbGeAlD
Gliclazide—Vomiting—Octreotide—thymus cancer	0.00279	0.00302	CcSEcCtD
Gliclazide—Rash—Octreotide—thymus cancer	0.00277	0.00299	CcSEcCtD
Gliclazide—Dermatitis—Octreotide—thymus cancer	0.00277	0.00299	CcSEcCtD
Gliclazide—Headache—Octreotide—thymus cancer	0.00275	0.00297	CcSEcCtD
Gliclazide—Nausea—Octreotide—thymus cancer	0.00261	0.00282	CcSEcCtD
Gliclazide—ALB—lymph node—thymus cancer	0.00185	0.025	CbGeAlD
